Browse by Tags

Related Posts
  • Blog Post: Supporting macmillan

    It has been a difficult week for all warriors with the loss of Debbie Brewer who was such an inspiration to so many. News also of other losses, some only in their forties with young families and our thoughts are with them. The devastation of this disease is felt by so many. I know you can’t measure...
  • Blog Post: Is there hope on the horizon?

    For the third year in a row, UCLA and the Pacific Heart, Lung and Blood Institute of Los Angeles organized a symposium focused on lung-sparing therapies for patients dealing with difficult-to-treat malignant pleural mesothelioma (MPM). According to a press release by the institute, this year’s...
  • Blog Post: Standing with our American friends to help combat mesothelioma

    A short while ago, I was contacted by Susan Vento whose husband Bruce - a serving congressman for the state of Minnesota - died as a result of mesothelioma. Susan is a spokesperson for the Asbestos Cancer Victims Rights Campaign (ACVRC). Recently in the states, asbestos companies have been using their...
  • Blog Post: An update on the NGR-hTNF and ADI-PEG trials for mesothlioma in the UK

    NGR-hTNF This is a study in second line treatment for patients with advanced mesothelioma who have been pre-treated with no more than one pemetrexed (aka Alimta) based chemotherapy regime. It's currently recruiting in Manchester, Maidstone, Leicester, Northwood, Glasgow, Sutton and London. The trial...
  • Blog Post: News of a nine year mesothelioma survivor

    The case of a German man who has lived more than 9 years with malignant mesothelioma is bringing attention to the drug that may have helped him defy the odds. The 67-year-old former German asbestos worker who is the subject of a new published report has stable mesothelioma, almost a decade after his...
  • Blog Post: T cells bouncing back after chemo good sign for immunotherapy success

    Mesothelioma patients whose T-cell counts bounce back quickly after a round of chemotherapy have a better chance of survival. They are also most likely to benefit from the addition of immunotherapy. That’s the conclusion of a British study looking for prognostic indicators in mesothelioma patients...
  • Blog Post: Good news scan stable

    Good news the scan shows no progression, still have the usual inflamation but no development in anything nasty since the last one six months ago. Here’s hoping everybody elses scan results are as good and thanks to everyone for their best wishes. We had the usual walk of doom to the appointment...
  • Blog Post: One more day to scan results

    Even more nerve wracking than exam day results, given the stakes involved, puts waiting for your GCSE’s in the shade- no retakes allowed with this one unfortunately. Have been majoring on distraction techniques the last couple of days, on Sunday we went to the Chelsea Autolegends show –...
  • Blog Post: Sad news as Canada prepares to reopen asbestos mine

    I’m amazed that for two countries who have access to all the info on asbestos this is actually happening. Firstly that Canada can be exporting something that is banned in their own country. Even more astonishing given the millions the USA is thankfully spending on research into mesothelioma that...
  • Blog Post: Immunotherapy shows promise for mesothelioma treatment

    A growing number of studies have pointed to the value of unconventional treatments like immunotherapy for mesothelioma.Immunotherapy refers to any treatment protocol which aims to harness the body’s own immune system to fight cancer cells. In a recent article in The Lancet Oncology , two National...